Myocardial heat shock protein 60 expression in insulin-resistant and diabetic rats

Journal of Endocrinology

Volumn 200, Issue 2, 2009, Pages 151-157

  Chen, Harn Shen ^a,b   Wu, Tzu En ^b   Juan, Chi Chang ^b   Lin, Hong Da ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; FRUCTOSE; HEAT SHOCK PROTEIN 60; INSULIN; PLACEBO; ROSIGLITAZONE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIABETES MELLITUS; FRUCTOSE INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHAPERONIN 60; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FRUCTOSE; GENE EXPRESSION; HYPERINSULINISM; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; THIAZOLIDINEDIONES;

EID: 67449136330     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0387     Document Type: Article

References (27)

1. Bunag RD 1973 Validation in awake rats of a tail-cuff method for measuring systolic blood pressure. Journal of Applied Physiology 34 279-282.
2. Chen HS, Shan XY, Yang TL, Lin H-D, Chen J-W, Lin S-J & Wang PH 2005 Insulin deficiency down-regulated Hsp60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 54 175-181.
3. Cornelussen RN, Vanagt WY, Prinzen FW & Snoeckx LH 2003 Proteins involved in salvage of the myocardium. Advances in Experimental Medicine and Biology 543 277-291.
4. DeFronzo RA & Ferrannini E 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 173-194.
5. Delogu G, Signore M, Mechelli A & Famularo G 2002 Heat shock proteins and their role in heart injury. Current Opinion in Critical Care 8 411-416.
6. Fang ZY, Prins JB & Marwick TH 2004 Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine Reviews 25 543-567.
7. Fein FS 1990 Diabetic cardiomyopathy. Diabetes Care 13 1169-1179.
8. Grossman E & Messerli FH 1996 Diabetic and hypertensive heart disease. Annals of Internal Medicine 125 304-310.
9. Hwang IS, Ho H, Hoffman BB & Reaven GM 1987 Fructose-induced insulin resistance and hypertension in rats. Hypertension 10 512-516.
10. Izaki K, Kinouchi H, Watanabe K, Owada Y, Okubo A, Itoh H, Kondo H, Tashima Y, Tamura S, Yoshimoto T et al. 2001 Induction of mitochondrial heat shock protein 60 and 10 mRNAs following transient focal cerebral ischemia in the rat. Brain Research. Molecular Brain Research 88 14-25.
11. Kirchhoff SR, Gupta S & Knowlton AA 2002 Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 105 2899-2904.
12. Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K et al. 2006 Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. Journal of Hypertension 24 1405-14712.
13. Kruszynska YT & Olefsky JM 1996 Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. Journal of Investigative Medicine 44 413-428.
14. Latchman DS 2001 Heat shock proteins and cardiac protection. Cardiovascular Research 51 637-646.
15. Lau S, Patnaik N, Sayen MR & Mestril R 1997 Simultaneous over-expression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation 96 2287-2294.
16. Lepore DA, Knight KR, Anderson RL & Morrison WA 2001 Role of priming stresses and Hsp70 in protection from ischemia-reperfusion injury in cardiac and skeletal muscle. Cell Stress and Chaperones 6 93-96.
17. Li G, Li RK, Mickle DA, Weisel RD, Merante F, Ball WT, Christakis GT, Cusimano RJ & Williams WG 1998 Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. Circulation 98 II144-II149.
18. Nathan DM 2002 Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. New England Journal of Medicine 347 1342-1349.
19. Panzram G 1987 Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30 123-131.
20. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA & Bennett PH 1991 A two-step model for development of non-insulin-dependent diabetes. American Journal of Medicine 90 229-235.
21. Sakai J, Ishikawa H, Kojima S, Satoh H, Yamamoto S & Kanaoka M 2003 Proteomic analysis of rat heart in ischemia and ischemia-reperfusion using fluorescence two-dimensional difference gel electrophoresis. Proteomics 3 1318-1324.
22. Schafler AE, Kirmanoglou K, Balbach J, Pecher P, Hannekum A & Schumacher B 2002 The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Research in Cardiology 97 258-261.
23. Shamaei-Tousi A, Steptoe A, O'Donnell K, Palmen J, Stephens JW, Hurel SJ, Marmot M, Homer K, D'Aiuto F, Coates AR et al. 2007 Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic, and biological factors. Cell Stress and Chaperones 12 384-392.
24. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS & Van Der Vusse GJ 2001 Heat shock proteins and cardiovascular pathophysiology. Physiological Reviews 81 1461-1497.
25. Sowers JR, Epstein M & Frohlich ED 2001 Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37 1053-1059.
26. Xu Q 2002 Role of heat shock proteins in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 22 1547-1559.
27. Yki-Jarvinen H 2004 Drug therapy: thiazolidinediones. New England Journal of Medicine 351 1106-1118.